Taiwan FDA Issues Warning Over Contaminated Banana Chips Batch from Indonesia Urgent Recall Action Required
On March 18, 2025, the Taiwan Food and Drug Administration (FDA) released a list of non-compliant foods at its borders, revealing that a batch of banana chips from Indonesia was found to have illegally added sweeteners.
The report identifies the manufacturer or exporter as GALEN SNACK, with the Taiwanese importer being Hsiang Yen Co., Ltd. The batch of banana chips tested positive for cyclohexylsulfamic acid at a level of 0.02 g/kg. According to the "Standards for the Use and Limits of Food Additives," the product does not meet the criteria set forth in Article 18 of the Food Safety and Sanitation Management Act.
A total of 84.00 kilograms of the non-compliant product has been either returned or destroyed to prevent any health risks.
Food safety authorities are urging domestic importers to remain vigilant and closely monitor relevant information to avoid importing non-compliant products. This incident highlights the importance of regulatory compliance to ensure consumer safety in the food supply chain.
2026-10-20
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
India Proposes New GMP Rules for Clinical Trial and API Manufacturing
-
U.S. Exempts Critical Chemical Manufacturers from Emissions Rules for Two Years
-
China Releases 15th Five-Year Carbon-Peaking Action Plan, Pushing Coal Chemicals into a Mandatory Low-Carbon Upgrade Cycle
-
FDA Color Policy Uncertainty Opens a New Chapter for Food Ingredient Reform
-
Bayer and Syngenta Score Consecutive Regulatory and Legal Wins in the U.S.
-
South Korea Expands Mandatory GMO Labeling to Highly Processed Foods
-
Vera’s New Kidney Drug Wins FDA Approval, Carrying a $425,000 Annual Price
-
Four Fine Chemical Units of Huajin Aramco Project – HDPE, EO/EG, etc. – Reach Mechanical Completion
-
关于将二氟乙咪酯等16种物质列入《非药用类麻醉药品和精神药品目录》的公告 Announcement on the Inclusion of 16 Substances including Difluoroetomidate in the Catalogue of Non-Medicinal Narcotic Drugs and Psychotropic Substances
-
MENA Pharmaceutical Regulatory Updates 2026: Key Compliance Changes for Global Pharma Companies
Recommend Reading
-
U.S. Formally Publishes India PFA Trade Cases, Raising New Barriers for Fluoropolymer Supply
-
China’s New Food-Contact Standards Take Effect, Resetting Compliance for Coatings and Silicone Rubber
-
EAEU Initiates Review of Anti-Dumping Measures on Chinese Titanium Dioxide, Suspends Duties During Investigation
-
U.S. Section 232 Pharmaceutical Tariffs Take Effect, With 100% Base Rate on Patented Drugs and APIs
-
U.S. and China Reach Consensus on More Favorable Tariff Treatment for $30 Billion of Goods Each Way
-
Glycopyrronium: Pharmaceutical Applications, Mechanism, and Chemical Specs
-
Business Society’s Market Outlook for Propylene Oxide on August 12, 2026: Price Trends Clearly Declining
-
Business Society’s Market Outlook for Epichlorohydrin on August 12, 2026: Price Trends Clearly Declining
-
Gellan Gum (E418): Vegan Thickener vs. Xanthan Gum in Food
-
Business Society’s PTA Market Outlook for September 1, 2026: Volatile